N. Schmitz

Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20⁺ B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL.

Michael Pfreundschuh, Marita Ziepert, Samira Zeynalova et al. · Journal of Clinical Oncology · 2011 · 48 citations

Medicine, Oncology, Aging +4

Improved outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL) after dose-dense rituximab: Results of the DENSE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Michael Pfreundschuh, Samira Zeynalova, Viola Poeschel et al. · Journal of Clinical Oncology · 2008 · 29 citations

Pharmacy, Oncology, Pharmacokinetics +15

Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis.

Christian Gisselbrecht, G. Laurent, Devinder Gill et al. · Journal of Clinical Oncology · 2011 · 22 citations

Medicine, Oncology, Pharmacotherapy +14

Two cases of graft-versus-host disease following transfusion of nonirradiated blood products

N. Schmitz, W. Kayser, Walter Gassmann et al. · Annals of Hematology · 1982 · 17 citations

Medicine, Hematology, Immunology +14

Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.

R. Hehlmann, H. Heimpel, Hossfeld Dk et al. · PubMed · 1996 · 17 citations

Medicine, Hematology, Pharmacotherapy +11